Augmenting Growth of the Radiotherapy Market Demand for Adopting Advanced Technologies for Cancer Management.

Radiotherapy is used for the treatment of cancer through high doses of radiation to kill cancer cells and shrink tumors. Radiotherapy uses ionizing radiations that deliver targeted beams of radiation to kill and destroy cancer cells, while minimizing damage to the healthy cells around them. It is commonly abbreviated RT, RTx, or XRT, is an internal radiotherapy treatment using ionizing radiation, usually delivered through a linear accelerator and designed to kill or control malignant cells within the body. Radiotherapy is usually used for cancers of the breast, lungs, ovaries, prostate, testicles, bones, brain, and abdominal organs. Sometimes, radiation therapy is used to treat chronic disorders such as pleurisy and meningitis.

Exclusive offer!!! Purchase the report at a discounted rate!!!

Flat Instant discount of US$ 2000

Buy This Complete A Business Report:
https://www.coherentMarketinsights.com/promo/buynow/1320

Increasing prevalence of oncology diseases, such as breast cancer, lung cancer, prostate cancer, etc., is increasing the demand for timely management to reduce the mortality associated with the aforementioned conditions. According to the World Health Organization (WHO), cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020. The most common type of cancer in 2020 (in terms of new cases of cancer) were: prostate (around 1.41 million cases), lung (around 2.21 million cases), and breast (around 2.26 million cases). This in turn is expected to increase the demand for radiotherapy (radiation therapy) all over the world, driving the growth of the radiotherapy market.

Growth of the radiotherapy market, in North America and the Asia Pacific, is mainly driven by the increasing prevalence of cancer in the aforementioned regions. According to the Centers for Disease Control and Prevention (CDC), in 2020, around 1,806,590 cases of cancer were expected to be diagnosed in the United States and 606,520 people were expected to die from the disease. Moreover, people are increasingly adopting novel therapies to reduce side effects associated with chemotherapy. Thus, there is an increasing demand for radiotherapy to treat cancer, which will further minimize the economic burden in the region. This in turn is expected to accelerate the growth of the radiotherapy market.

Furthermore, standardized approaches in external beam radiotherapy and brachytherapy have been developed through scientific discoveries, trial and error, and technological advances. Various types of radiotherapies, such as intensity modulated radiotherapy (IMRT), conformal radiotherapy (CRT), 4-dimensional radiotherapy, and image guided radiotherapy (IGRT) are widely used for the treatment of cancer. Radiotherapy is increasingly being adopted for cancer treatment due to its cost-effectiveness. Thus, the radiotherapy market is growing rapidly along with the worldwide adoption of radiotherapy for cancer treatment.

For Customization on this Report @ https://www.coherentmarketinsights.com/insight/request-customization/1320

Major Market Competitors

Accuray Incorporated, Varian Medical Systems, Inc., Elekta AB, Ion Beam Applications S.A., C.R. Bard, Inc., Isoray Medical, Inc., CIVCO Radiotherapy, Hitachi Ltd., Mevion Medical Systems, Inc., and ProTom International, Inc.

Detailed Segmentation:

Global Radiotherapy Market, By Product Type:
External Beam Radiation
Compact Advanced Radiotherapy Systems
Cyber Knife
Gamma Knife
Others
Proton Therapy Systems
Synchrotron
Cyclotron
High Energy Linear Accelerators (LINAC)
Internal Beam Radiation
Applicators
Afterloader
Seeds
Capnographs
Gas Analyzers
Systemic Radiation
Global Radiotherapy Market, By Therapy Type:
External Beam Radiation Therapy
Stereotactic Radiosurgery (SRS)
Stereotactic Body Radiation Therapy (SBRT)
Intensity-modulated Radiation Therapy (IMRT)
Proton Therapy
Image-guided Radiotherapy (IGRT)
Volumetric Modulated Arc Therapy (VMAT)
Others
Internal Beam Radiation Therapy
Low-dose Rate Brachytherapy (LDR)
High-dose Rate Brachytherapy (HDR)
Image-guided Brachytherapy (IGBT)
Pulse Dose Rate Brachytherapy (PDR)
Systemic Radiation Therapy
Oral Radiotherapy
Intravenous Radiotherapy
Global Radiotherapy Market, By Application:
Prostate Cancer
Breast Cancer
Lung Cancer
Colorectal Cancer
Cervical Cancer
Others
Global Radiotherapy Market, By End User:
Hospitals
Oncology Clinics
Ambulatory Radiotherapy Centers
Others

Download PDF Sample Report @
https://www.coherentmarketinsights.com/insight/request-sample/1320
Covid-19 Impact:

The COVID-19 pandemic has exacerbated the world’s healthcare challenges. Social distancing and shutdowns have accelerated adoption of digital technologies in the healthcare sector. Our updated reports have answers to various concerns in the global Radiotherapy market caused due to the pandemic.

Contact us:
Mr. Shah
Senior Client Partner – Business Development
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
sales@coherentMarketinsights.com

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

This release was published on openPR.